Condition: Cardiovascular Diseases · Sponsor: AstraZeneca
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multi-center, prospective, and interventional study conducted in 3 types of cardiovascular diseases (CVD) participants , including 3 cohorts which are patients with newly or previously diagnosed coronary heart disease ( CHD), atrial fibrillation ( AF) and chronic heart failure (CHF).
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Anqing, China | Not Yet Recruiting |
| Research Site | Beijing, China | Recruiting |
| Research Site | Beijing, China | Not Yet Recruiting |
| Research Site | Beijing, China | Not Yet Recruiting |
| Research Site | Beijing, China | Not Yet Recruiting |
| Research Site | Beijing, China | Recruiting |
| Research Site | Changsha, China | Not Yet Recruiting |
| Research Site | Changsha, China | Recruiting |
| Research Site | Chaohu, China | Not Yet Recruiting |
| Research Site | Chengdu, China | Not Yet Recruiting |
| Research Site | Chengdu, China | Not Yet Recruiting |
| Research Site | Chengdu, China | Recruiting |
+ 73 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.